DexCom, Inc. DXCM reported first-quarter 2025 adjusted earnings per share (EPS) of 32 cents, which missed the Zacks Consensus Estimate of 33 cents by 3 ... G7 System, which features improved ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...

Discover Dexcom's Q1 2025 earnings highlights, including 14% revenue growth, expanded type 2 diabetes coverage, and the upcoming launch of the 15-day ...

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus forecast.

DexCom (DXCM) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.32 per share a year ago. These figures ...

The tech-heavy Nasdaq led the rally among all major indices, finishing up by 1.51 percent ... our product portfolio with the launch of our Dexcom G7 15-Day system and continue to advocate for ...